Cargando…

MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia

BACKGROUND: Tyrosine kinase inhibitors (TKIs) are the recommended treatment for patients with chronic myeloid leukemia (CML). The MDR1/ABCB1 gene plays a role in resistance to a wide spectrum of drugs, including TKIs. However, the association of MDR1/ABCB1 gene polymorphisms (SNPs) such as C1236T, G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lardo, Mabel, Castro, Marcelo, Moiraghi, Beatriz, Rojas, Francisca, Borda, Natalia, Rey, Jorge A, Lazarowski, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595581/ https://www.ncbi.nlm.nih.gov/pubmed/26457282 http://dx.doi.org/10.5045/br.2015.50.3.154

Ejemplares similares

The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer
por: Mrozikiewicz-Rakowska, Beata, et al.
Publicado: (2019)

ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer
por: Balcerczak, Ewa, et al.
Publicado: (2010)

Super analgesia of intrathecal morphine may be related to ABCB1 (MDR1) gene polymorphism
por: Qin, Wangjun, et al.
Publicado: (2018)

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
por: Galimberti, Sara, et al.
Publicado: (2017)

A Comprehensive Investigation on Common Polymorphisms in the MDR1/ABCB1 Transporter Gene and Susceptibility to Colorectal Cancer
por: Campa, Daniele, et al.
Publicado: (2012)

Impact of ABCB1 Gene Polymorphisms and Smoking on the Susceptibility Risk of Chronic Myeloid Leukemia and Cytogenetic Response
por: Mohammadi, Fatemeh, et al.
Publicado: (2021)

Association Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virus
por: Timucin, Meryem, et al.
Publicado: (2013)

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia
por: Geers, Lisanne M., et al.
Publicado: (2020)

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
por: Maia, Raquel C., et al.
Publicado: (2018)

Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
por: Boyer, Thomas, et al.
Publicado: (2019)

Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
por: Corrêa, Stephany, et al.
Publicado: (2012)

Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
por: Loscocco, Federica, et al.
Publicado: (2021)

Polymorphism of ABCB1/MDR1 C3435T in Children and Adolescents with Partial Epilepsy is due to Different Criteria for Drug Resistance – Preliminary Results
por: Emich-Widera, Ewa, et al.
Publicado: (2014)

Association of Multidrug Resistance Gene-1 (MDR1 C1236T) Polymorphism with the Risk of Acute Myeloid Leukemia in a Moroccan Population
por: Boujmia, Oum Kaltoum Ait, et al.
Publicado: (2020)

Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
por: Besse, A, et al.
Publicado: (2018)

PB1790: ABCB1 AS A POTENTIAL BENEFICIAL TARGET OF MIDOSTAURIN IN ACUTE MYELOID LEUKEMIA
por: Sucha, S., et al.
Publicado: (2022)

Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients
por: Senhaji, Nezha, et al.
Publicado: (2015)

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia
por: Gregers, J, et al.
Publicado: (2015)

Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice
por: Brenn, Anja, et al.
Publicado: (2011)

ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
por: Bedewy, Ahmed M. L., et al.
Publicado: (2019)

Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines
por: Krzyzanowski, Damian, et al.
Publicado: (2021)

Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia
por: Abdulkareem, Rafid A., et al.
Publicado: (2020)

Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2010)

The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
por: Yin, Wang, et al.
Publicado: (2021)

OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2014)

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma
por: Walsh, Naomi, et al.
Publicado: (2009)

ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
por: Vaidyanathan, Aparajitha, et al.
Publicado: (2016)

ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
por: Mugosa, Snezana, et al.
Publicado: (2021)

SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
por: Singh, Onkar, et al.
Publicado: (2012)

ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis
por: Ma, Limin, et al.
Publicado: (2015)

Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene
por: Rosmorduc, Olivier, et al.
Publicado: (2007)

Detergent Screening and Purification of the Human Liver ABC Transporters BSEP (ABCB11) and MDR3 (ABCB4) Expressed in the Yeast Pichia pastoris
por: Ellinger, Philipp, et al.
Publicado: (2013)

Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia
por: Madejczyk, Anna Marta, et al.
Publicado: (2022)

The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
por: Zmorzynski, Szymon, et al.
Publicado: (2021)

The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment
por: Tulsyan, Sonam, et al.
Publicado: (2016)

Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis
por: Yan, Yulan, et al.
Publicado: (2013)

Hepatobiliary anomalies associated with ABCB4/MDR3 deficiency in adults: a pictorial essay
por: Benzimra, Julie, et al.
Publicado: (2013)

Monomeric bile acids modulate the ATPase activity of detergent-solubilized ABCB4/MDR3
por: Kroll, Tim, et al.
Publicado: (2021)

Pharmacogenetics of ABCB1 , CDA , DCK , GSTT1 , GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia
por: Yunis, Luz K., et al.
Publicado: (2022)

Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
por: Liu, Tang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1at6foeou57n7s7uh6rgpkro81